Day One Bio aims to bring new cancer therapies to pediatric patients faster amid evolving financial incentives, such as the ...
A clinical trial comparing a one-page medication handout proposed by the U.S. Food and Drug Administration (FDA) with an ...
Zacks.com on MSN1d
RARE Reports New Upbeat Data From Sanfilippo Syndrome Drug StudyUltragenyx Pharmaceutical RARE reported new findings from an ongoing, pivotal study of its investigational candidate, UX111 (ABO-102) AAV gene therapy, for Sanfilippo syndrome type A (MPS IIIA). Per ...
Cumberland Pharmaceuticals' Phase 2 trial shows ifetroban improves heart function in Duchenne muscular dystrophy patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback